Zurueck zur Suche

Reporte zur Charge U028183

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WA 1 UT 1 CA 1 OR 1 CO 1 ID 1 NV 1

VAERS 2579625

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U028183

schwer
Staat
WA
Alter
11,0
Geschlecht
F
Eingang
10.02.2023
Impfdatum
09.02.2023
Beginn
09.02.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Supine position Syncope

Symptomtext

Upon administration of Kinrix in left deltoid, patient experienced a syncopal episode. This was the fourth and final vaccine administered at this visit. Patient collapsed backwards onto exam table. Dr. was called in to examine. Dr. determined this to be a syncopal episode. Patient was not postictal and was not presenting with signs of anaphylactic reaction. Pt was alert and conscious after approximately 30 seconds from time of syncopal episode. Patient reported experiencing dizziness and light-headedness. Patient was positioned supine for 30 minutes. Patient drank juice box and reported resolution of symptoms. Patient was monitored for a total of 40 minutes from time of episode. Patient was able to ambulate normally and went home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
No history of syncopal episodes per mother.
Aktuelle Erkrankungen
None documented
Vorgeschichte
Intermittent Explosive Disorder
Andere Medikamente
Vitamin C, Multivitamin, Probiotic
Allergien
None documented
Vorherige Impfungen
-

VAERS 2417649

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u028183

mild
Staat
UT
Alter
5,0
Geschlecht
F
Eingang
22.08.2022
Impfdatum
15.08.2022
Beginn
16.08.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pain Injection site reaction Injection site warmth Local reaction

Symptomtext

Large local reaction to anterior aspect fo R thigh. Erythema, tenderness and warm to touch. Has used an ice pack yesterday. Did not cross joints or extend around thigh. Was improving when seen in office 2 days after reaction began.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2173934

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u028183

mild
Staat
CA
Alter
11,0
Geschlecht
M
Eingang
11.03.2022
Impfdatum
09.03.2022
Beginn
09.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cough Injection site erythema Injection site swelling Local reaction

Symptomtext

After Proquad given family noted small redness at injection site. MD called and evaluated, no infection, suspected mild local reaction about dime size. 2 days later called by parent, concerned redness swelling, wanted report made to VAERS. No fever, able to move arm, no other symptoms except maybe a mild cough.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2173271

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U028183

mild
Staat
OR
Alter
1,0
Geschlecht
F
Eingang
11.03.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Injection site rash Injection site swelling

Symptomtext

Patient Immediately developed small rash and swelling at the site of injection. Swelling and rash was evaluated by provider and dissipated and was gone in 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2584426

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U028183

gering
Staat
CO
Alter
59,0
Geschlecht
F
Eingang
21.02.2023
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

no additional AE's were reported; an adult patient was administered a dose of PROQUAD; This spontaneous report was received from a medical assistant and refers to a 59-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 21-APR-2022, the adult patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (recombinant human albumin) (PROQUAD) subcutaneous injection, at dose of 0.5 milliliter, lot number U028183 was verified to be a valid number, expiration date reported and established as 08-MAR-2023, administered subcutaneously for prophylaxis (strength was not provided) (product administered to patient of inappropriate age). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479816

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U028183

gering
Staat
ID
Alter
-
Geschlecht
U
Eingang
17.10.2022
Impfdatum
29.09.2022
Beginn
29.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; an improperly stored dose of PROQUAD was administered to the patient on 29SEP2022; This spontaneous report was received from a medical assistant referring to a patient of unknow gender and age. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On 29-SEP-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA) 0.5 milliliter, lot #U028183, expiration date: 08-MAR-2023, administered for prophylaxis (strength, and route of administration were not provided) (product storage error). The temperature was 11.1 Fahrenheit (F), and time frame was 3 hours and 25 minutes. There was no previous temperature excursion. No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2242819

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U028183

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
20.04.2022
Impfdatum
-
Beginn
01.04.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse events; Caller is HCP who reported that patient received dose of PROQUAD that has experienced temperature excursion. No additional adverse events/no product quality complaints.; Information has been received from a medical assistant, referring to a 4 year -old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # U028183 and expiration date on 08-MAR-2023 (administration route was not provided) for prophylaxis. No adverse effects were reported. No additional details regarding the temperature excursion was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-